ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Special Note Regarding Forward Looking Statements

This report contains forward-looking statements that are contained principally in the sections entitled “Our Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the factors described in the section captioned “Risk Factors” in our latest annual report on Form 10-K filed with the SEC. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “would” and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements include, among other things, statements relating to:

• our expectations regarding growth in the motor sports market;
• our expectation regarding increasing demand for protective equipment used in the motor sports market;
• our belief that we will be able to effectively compete with our competitors and increase our market share;
• our expectations with respect to increased revenue growth and our ability to achieve profitability resulting from increases in our production volumes; and
• our future business development, results of operations and financial condition.

Also, forward-looking statements represent our estimates and assumptions only as of the date of this annual report. You should read this annual report and the documents that we reference and filed as exhibits to the annual report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

Use of Certain Defined Terms

Except as otherwise indicated by the context, references in this annual report to:

• “Leatt,” “we,” “us,” “our,” the “Registrant” or the “Company” are to the combined business of Leatt Corporation, a Nevada corporation, its South African branch, Leatt SA, and its direct, wholly-owned subsidiaries, Two Eleven and Three Eleven;
• “Leatt SA” are to the Company’s branch office known as ‘Leatt Corporation (Incorporated in the State of Nevada)’ incorporated under the laws of South Africa with registration number: 2007/032780/10;
• “Leatt USA” are to Leatt USA, LLC, a Nevada Limited Liability Company;
• “PRC”, and “China” are to the People’s Republic of China;
• “Two Eleven” refers to Two Eleven Distribution, LLC, a California limited liability company;
• “Three Eleven” are to Three Eleven Distribution (Pty) Limited, a South African Company;
• “Securities Act” are to the Securities Act of 1933, as amended, and to “Exchange Act” are to Securities Exchange Act of 1934, as amended;
• “South Africa” are to the Republic of South Africa;
• “U.S. dollar,” “$” and “US$” are to the legal currency of the United States.
• “Xceed Holdings” refers to Xceed Holdings CC., a close corporation incorporated under the laws of South Africa, and wholly- owned by The Leatt Family Trust, of which Dr. Christopher J. Leatt, the Company’s chairman, is a Trustee and Beneficiary; and
• “ZAR” refers to the South African Rand, the legal currency of South Africa. For all ZAR amounts reported, the dollar amount has been calculated on the basis that $1 = ZAR 14.0446 for its June 30, 2019 balance sheet .

Overview of our Business

We were incorporated in the State of Nevada on March 11, 2005 under the name Treadzone, Inc. We were a shell company with little or no operations until March 1, 2006, when we acquired the exclusive global manufacturing, distribution, sale and use rights to the Leatt-Brace®, pursuant to a license agreement between the Company and Xceed Holdings, a company owned and controlled by the Company’s Chairman and founder, Dr. Christopher Leatt. On May 25, 2005, we changed our name to Leatt Corporation in connection with our anticipated acquisition of the Leatt-Brace® rights. Leatt designs, develops, markets and distributes personal protective equipment for participants in all forms of motor sports and leisure activities, including riders of motorcycles, bicycles, snowmobiles and ATVs. The Company sells its products to customers worldwide through a global network of distributors and retailers. Leatt also acts as the original equipment manufacturer for neck braces sold by other international brands.

13

The Company’s flagship products are based on the Leatt-Brace® system, a patented injection molded neck protection system owned by Xceed Holdings, designed to prevent potentially devastating injuries to the cervical spine and neck. The Company has the exclusive global manufacturing, distribution, sale and use rights to the Leatt-Brace®, pursuant to a license agreement between the Company and Xceed Holdings, a company owned and controlled by the Company’s Chairman and founder, Dr. Christopher Leatt. The Company also has the right to use apparatus embodying, employing and containing the Leatt-Brace® technology and has designed, developed, marketed and distributed other personal protective equipment using this technology, as well as its own developed technology, including the Company’s new body protection products which it markets under the Leatt Protection Range brand.

The Company’s research and development efforts are conducted at its research facilities, located at its executive headquarters in Cape Town, South Africa. The Company employs 3 full-time employees who are dedicated exclusively to research, development, and testing. The Company also utilizes consultants, academic institutions and engineering companies as independent contractors or consultants, from time to time, to assist it with its research and development efforts. Leatt products have been tested and reviewed internally and by external bodies. All Leatt products are compliant with applicable European Union directives, or CE certified, where appropriate. Depending on the market we have other certifications outside of CE. For the US market our motorcycle helmets comply with the DOT (FMVSS 218) helmet safety standard and our bicycle helmet complies with EN1078, as well as CPSC 1203. Our downhill specific bicycle helmets also comply with ASTM F1952. For our Australian Market our bicycle helmet complies with AS/NZS 2063. For the UK market our motorcycle helmets comply with ACU Gold. We are also in the process of certifying our GPX 3.5 helmet with JIS T 8133 for the Japanese Market.

Our products are manufactured in China under outsource manufacturing arrangements with third-party manufacturers located there. The Company utilizes outside consultants and its own employees to ensure the quality of its products through regular on-site product inspections. Products purchased through international sales are usually shipped directly from our manufacturers’ warehouses or points of dispatch to customers or their import agents.

Leatt earns revenues through the sale of its products through approximately 60 distributors worldwide, who in turn sell its products to retailers. Leatt distributors are required to follow certain standard business terms and guidelines for the sale and distribution of Leatt products. Two Eleven and Leatt SA directly distribute Leatt products to retailers in the United States and South Africa, respectively.

Principal Factors Affecting Our Financial Performance

We believe that the following factors will continue to affect our financial performance:

• Global Economic Fragility – The ongoing turmoil in the global economy, especially in the U.S., Asia and Europe, may have an impact on our business and our financial condition, and we may face challenges if economic conditions do not improve. These economic conditions impact levels of consumer spending, which have deteriorated and may remain depressed for the foreseeable future. If demand for our products fluctuates as a result of these economic conditions or otherwise, our revenue and gross margin could be harmed.
   

• Fuel Prices – Significant fluctuations in fuel prices could have both a positive and negative effect on our business and operations. A significant portion of our revenue is derived from international sales and significant fluctuations in world fuel prices could significantly increase the price of shipping or transporting our products which we may not be able to pass on to our customers. On the other hand, fluctuations in fuel prices lead to higher commuter costs which may encourage the increased use of motorcycles and bicycles as alternative modes of transportation and lead to an increase in the market for our protection products.
   

• Product Liability Litigation – We face an inherent business risk of exposure to product liability claims arising from the claimed failure of our products to help prevent the types of personal injury or death against which they are designed to help protect. Therefore, we have acquired very costly product liability insurance worldwide. We have not experienced any material uninsured losses due to product liability claims, but it is possible that we could experience material losses in the future. After a two-week trial in the United States District Court for the Northern District of Ohio (Eastern) ending on April 17, 2014, a federal jury returned a defense verdict for the Company in the first Leatt- Brace® product liability lawsuit to be tried in the United States. The plaintiffs in that case had alleged that defective product design and failure to warn had caused a motocross rider to suffer multiple mid-thoracic spine fractures, causing immediate and permanent paraplegia, when he crashed at a relatively low speed on February 13, 2011. When the accident occurred, he was wearing a helmet and other safety gear from several different companies, including the Company's acclaimed Leatt- Brace®. The Company produced evidence at trial showing that his thoracic paraplegia was an unavoidable consequence of his fall, not the result of wearing a Leatt- Brace®, and that the neck brace likely saved his life (or saved him from quadriplegia) by preventing cervical spine injury. The Company had maintained from the onset that this and a small handful of other lawsuits are without merit and that it would vigorously defend itself in each case. In this case, the plaintiffs subsequently appealed the court’s decision and the parties reached an amicable settlement. Although we carry product liability insurance, a successful claim brought against us could significantly harm our business and financial condition and have an adverse impact on our ability to renew our product liability insurance or secure new coverage.
  

14

• Protection of Intellectual Property – We believe that the continued success of our business is dependent on our intellectual property portfolio consisting of globally registered trademarks, design patents and utility patents related to the Leatt-Brace®. We believe that a loss of these rights would harm or cause a material disruption to our business and, our corporate strategy is to aggressively take legal action against any violators of our intellectual property rights, regardless of where they may be. From time to time, we have had to enforce our intellectual property rights through litigation and we may be required to do so in the future. Such litigation may result in substantial costs and could divert resources and management attention from the operations of our business.
  
  

• Fluctuations in Foreign Currencies – We are exposed to foreign exchange risk as our revenues and consolidated results of operations may be affected by fluctuations in foreign currency as we translate these currencies into U.S. dollars when we consolidate our financial results. While our reporting currency is the U.S. Dollar, a portion of our consolidated revenues are denominated in South African Rand, or ZAR, certain of our assets are denominated in ZAR, and our research and marketing operations in South Africa utilize South African labor sources. A decrease in the value of the U.S. dollar in relation to the ZAR could increase our cost of doing business in South Africa. If the ZAR depreciates against the U.S. Dollar, the value of our ZAR revenues, earnings and assets as expressed in our U.S. Dollar financial statements will decline. We have not entered into any hedging transactions in an effort to reduce our exposure to foreign exchange risk. Furthermore, since 66% of our sales is derived outside the U.S., where the U.S. dollar is not the primary currency, significant fluctuations in exchange rates such as the strengthening of the dollar versus our customers’ local currency can adversely affect our ability to remain competitive in those areas.

Results of Operations

The following summary of our results of operations should be read in conjunction with our financial statements and the notes thereto for the three- and six-month periods ended June 30, 2019 and 2018 included herein.

Three Months Ended June 30, 2019 compared to the Three Months Ended June 30, 2018

The following table summarizes the results of our operations during the three-month periods ended June 30, 2019 and 2018 and provides information regarding the dollar and percentage increase or (decrease) in such periods:

15

Revenues – We earn revenues from the sale of our protective gear comprising of neck braces, body armor, helmets and other products, parts and accessories both in the United States and abroad. Revenues for the three months ended June 30, 2019 were $5.28 million, a 10% increase, compared to revenues of $4.80 million for the quarter ended June 30, 2018. Revenues associated with international customers were $2.96 million and $2.57 million, or 56% and 53% of revenues, respectively, for the three months ended June 30, 2019 and 2018. This increase in worldwide revenues is primarily attributable to a $0.06 million increase in neck brace sales, a $0.53 million increase in body armor sales and a $0.33 million increase in sales of other products, parts and accessories that were partially offset by a $0.43 million decrease in helmet sales.

The following table sets forth our revenues by product line for the three months ended June 30, 2019 and 2018:

16

Sales of our flagship neck brace accounted for $1.32 million and $1.26 million, or 25% and 26% of our revenues for the quarters ended June 30, 2019 and 2018, respectively. The 5% increase in neck brace revenues during the 2019 second quarter is primarily attributable to a 5% increase in the volume of neck braces sold to our customers worldwide during the period.

Our body armor products are comprised of chest protectors, full upper body protectors, upper body protection vests, back protectors, knee braces and knee and elbow guards. Body armor sales accounted for $2.81 million and $2.28 million, or 53% and 47% of our revenues for the quarters ended June 30, 2019 and 2018, respectively. The 23% increase in body armor revenues during the 2019 second quarter is primarily the result of a 69% increase in the volume of knee braces sold during the period due to increased worldwide demand for our line of medically certified, revolutionary knee braces.

Our helmets accounted for $0.46 million and $0.89 million or 9% and 19% of our revenues for the three months ended June 30, 2019 and 2018, respectively. The $0.43 million decrease in helmet sales during the 2019 second quarter is primarily due to a 55% decrease in the volume of helmets sold during the 2019 period.

Our other products, parts and accessories are comprised of aftermarket support items required primarily to replace worn or damaged parts through our global distribution network, as well as clothing, outerwear and accessories that include hats, jackets, bags, hydration kits and cooling garments. Other products, parts and accessories sales accounted for $0.70 million and $0.37 million, or 13% and 8% of our revenues for the quarters ended June 30, 2019 and 2018, respectively. The 88% increase in revenues from the sale of other products, parts and accessories during the 2019 second quarter is primarily due to the continued global shipment of our innovative Velocity 6.5 line of goggles to our customers.

Cost of Revenues and Gross Profit – Cost of revenues for the quarters ended June 30, 2019 and 2018 were $2.65 million and $2.44 million, respectively. Gross Profit for the quarters ended June 30, 2019 and 2018 were $2.63 million and $2.36 million, respectively, or 50% and 49% of revenues respectively. Our neck brace products continue to generate a higher gross margin than our other product categories. Although our neck brace revenues accounted for 25% and 26% of our revenues for the quarters ended June 30, 2019 and 2018 respectively, gross margins on our body armor products and particularly our line of knee braces continued to improve. Body armor revenues accounted for 53% and 47% of our revenues for the quarters ended June 30, 2019 and 2018 respectively.

Product Royalty Income – Product royalty income is earned on sales to distributors that have royalty agreements in place, as well as on sales of licensed products by third parties that have licensing agreements in place. Product royalty income for the quarters ended June 30, 2019 and 2018 were $6,995 and $7,802, respectively. The 10% decrease in product royalty income is due to a decrease in the sale of licensed products by licensees in the 2019 period.

Salaries and Wages – Salaries and wages for the quarters ended June 30, 2019 and 2018 were $713,736 and $617,552, respectively. This 16% increase in salaries and wages during the 2019 period was primarily due to the employment of additional in-house sales personnel based in the United States and sales and marketing staff based in Europe.

Commissions and Consulting Expense – During the quarters ended June 30, 2019 and 2018, commissions and consulting expenses were $80,499 and $133,575, respectively. This 40% decrease in commissions and consulting expenses is primarily due to a decrease in commissions paid to the external sales personnel in the United States in line with the Company’s employment of in-house sales personnel.

Professional Fees – Professional fees consist of costs incurred for audit, tax and regulatory filings, as well as patent protection and product liability litigation expenses incurred as the Company continues to expand. Professional fees for the quarters ended June 30, 2019 and 2018 were $131,569 and $128,987, respectively. This 2% increase in professional fees is primarily due to increased spending on patent litigation as the Company continues to protect its intellectual property rights.

Advertising and Marketing – The Company places paid advertising in various motorsport magazines and online media, and sponsors a number of events, teams and individuals to increase product and brand visibility. Advertising and marketing expenses for the quarters ended June 30, 2019 and 2018 were $471,888 and $458,450, respectively. The 3% increase in advertising and marketing expenditures during the 2019 period is primarily due to the production and implementation of global marketing campaigns incorporating web based advertising, social media outreach and athlete sponsorships in key market areas that are designed to promote the Company’s expanding product range and global brand.

Office Lease and Expenses – Office lease and expenses for the quarters ended June 30, 2019 and 2018 were $68,546 and $71,321, respectively. This 4% decrease in office lease and expenses during the 2019 period was primarily due to a decrease in utility expenditure incurred in the United States during the 2019 period.

17

Research and Development Costs – These costs consist of the salaries of personnel who are directly involved in the research and development of innovative products, as well as the direct costs associated with developing these products. Research and development costs for the quarter ended June 30, 2019 decreased to $366,219, from $378,912 during the same 2018 quarter. The 3% decrease in research and development costs during the 2019 second quarter is as a result of significant CE certification and homologation costs incurred during the 2018 period.

Bad Debt Expense (Recovery) – Bad Debt Expense (Recovery) for the quarters ended June 30, 2019 and 2018 were ($7,022) and $10,705, respectively. This decrease in Bad Debt Expense (Recovery) is primarily the result of a decrease in the Provision for doubtful accounts in line with a decrease in Accounts receivable.

General and Administrative Expenses – General and administrative expenses consist of insurance, travel, merchant fees, telephone, office and computer supplies. General and administrative expenses for the quarters ended June 30, 2019 and 2018 were $521,420 and $454,156, respectively. The 15% increase in general and administrative expenses is primarily due to increased travel expenditure incurred on dealer sales visits in the United States and manufacturer visits globally as the Company continues to grow its product categories and line up.

Depreciation Expense – Depreciation Expense for the quarters ended June 30, 2019 and 2018 were $188,300 and $165,011, respectively. This 14% increase in depreciation during the 2019 second quarter is primarily due to the addition of molds and tooling utilized in the production of the Company’s widening product range.

Total Operating Expenses – Total operating expenses increased by $116,486 to $2.54 million in the three months ended June 30, 2019, or 5%, compared to $2.42 million in the 2018 period. This increase is primarily due to increased general and administrative costs and salaries and wages that were partially offset by a decrease in commission and consulting costs.

Net income (loss) – The net income after income taxes for the quarter ended June 30, 2019 was $73,700 as opposed to a net loss after income taxes of $49,455 for the quarter ended June 30, 2018. This increase in net income is primarily due to the increase in revenues and gross profit discussed above.

Revenues – We earn revenues from the sale of our protective gear comprising of neck braces, body armor, helmets and other products, parts and accessories both in the United States and internationally. Revenues for the six months ended June 30, 2019 were $11.37 million, a 10% increase, compared to $10.30 million for the six months ended June 30, 2018. Revenues generated from sales to our customers in the United States increased from $4.32 million to $4.40 million, for the six months ended June 30, 2019 and 2018, respectively. Revenues associated with international customers were $6.97 million and $5.98 million, or 61% and 58% of revenues, respectively, for the six months ended June 30, 2019 and 2018. This increase in global revenues during the 2018 period is attributable to a $0.68 million increase in body armor sales and a $0.99 million increase in sales of other products, parts and accessories that were partially offset by a $0.24 million decrease in neck brace sales and a $0.35 million decrease in helmet sales.

The following table sets forth our revenues by product line for the six months ended June 30, 2019 and 2018:

19

Sales of our flagship neck brace accounted for $2.68 million and $2.92 million, or 24% and 29% of our revenues for the six-month periods ended June 30, 2019 and 2018, respectively. The 8% decrease in neck brace revenues is primarily attributable to a decrease in the volume of neck braces sold to our customers globally. The Company shipped initial stocking shipments of our highly anticipated 3.5 neck brace for off-road motorcycle and bicycle use during the first quarter of 2018 which resulted in strong comparative neck brace sales.

Our body armor products are comprised of chest protectors, full upper body protectors, upper body protection vests, back protectors, knee braces and knee and elbow guards. Body armor sales accounted for $5.23 million and $4.55 million, or 46% and 44% of our revenues for the six-month period ended June 30, 2019 and 2018, respectively. The 15% increase in body armor revenues was primarily the result of a 58% increase in the volume of knee braces sold during the six months ended June 30, 2019 due to increased customer demand in the United States and abroad.

Our Helmets accounted for $1.43 million and $1.79 million, or 12% and 17% of our revenues for the six-month periods ended June 30, 2019 and 2018, respectively. The $0.35 million decrease in helmet sales during the 2019 period is primarily due to a 26% decrease in the volume of helmets sold during the 2019 period. Although sales volumes of our Convertible DBX 3.0 Enduro and DBX 4.0 helmets for bicycle use, and our GPX 3.5 helmet for motorcycle use continued to grow, sales volumes of our GPX 5.5 helmet for off-road motorcycle use decreased for the period ended June 30, 2019 when compared to the prior period, particularly in the United States.

Our other products, parts and accessories are comprised of aftermarket support items required primarily to replace worn or damaged parts through our global distribution network, as well as clothing, outerwear and accessories that include hats, jackets, bags, hydration kits and cooling garments. Other products, parts and accessories sales accounted for $2.02 million and $1.04 million or 18% and 10% of our revenues for the six-month periods ended June 30, 2019 and 2018, respectively. The 95% increase in revenues from the sale of other products, parts and accessories is primarily due to initial shipments of our innovative Velocity 6.5 line of goggles to our customers in the United States and abroad.

Cost of Revenues and Gross Profit – Cost of revenues for the six-months ended June 30, 2019 and 2018 were $5.88 million and $5.19 million, respectively. Gross Profit for the six-month periods ended June 30, 2019 and 2018 were $5.49 million and $5.11 million, respectively, or 48% and 50% of revenues respectively. Our neck brace products continue to generate a higher gross profit margin than other product categories. Neck brace revenues accounted for 24% and 29% of our revenues for the six months ended June 30, 2019 and 2018, respectively.

Product Royalty Income – Product royalty income is earned on sales to distributors that have royalty agreements in place, as well as on sales of licensed products by third parties that have licensing agreements in place. Product royalty income for the six-month periods ended June 30, 2019 and 2018 were $15,696 and $20,111, respectively. The 22% decrease in product royalty income is due to a decrease in the sale of licensed products by licensees in the 2019 period.

Salaries and Wages – Salaries and wages for the six-month periods ended June 30, 2019 and 2018 were $1,590,640 and $1,395,315, respectively. This 14% increase in salaries and wages during the 2019 period was primarily due to the employment of additional in-house professional sales personnel in the United States and sales and marketing staff that are based in Europe during the six months ended June 30, 2019.

Commissions and Consulting Expense – During the six-month periods ended June 30, 2019 and 2018, commissions and consulting expenses were $158,560 and $258,914, respectively. This 39% decrease in commissions and consulting expenses during the 2019 period is primarily the result of decreased sales commissions paid to external sales representatives in the United States as the Company continues to employ professional sales personnel on a permanent basis.

Professional Fees – Professional fees consist of costs incurred for audit, tax and regulatory filings, as well as patent protection and product liability litigation expenses incurred as the Company continues to expand. Professional fees for the six-month periods ended June 30, 2019 and 2018 were $384,537 and $297,458, respectively. This 29% increase in professional fees is primarily due to increased spending on product liability litigation during the 2019 period.

Advertising and Marketing – The Company places paid advertising in various motorsport magazines and online media, and sponsors a number of events, teams and individuals to increase product and brand visibility. Advertising and marketing expenses for the six-months ended June 30, 2019 and 2018 were $1,035,882 and $962,612, respectively. The 8% increase in advertising and marketing expenditures during the 2019 period is primarily due to the production and implementation of marketing campaigns that incorporate strategic paid media placements and athlete sponsorships designed to globally support and promote the Company’s widening product range, target market reach and increase consumer awareness of the Leatt brand.

20

Office Lease and Expenses – Office lease and expenses for the six-month periods ended June 30, 2019 and 2018 were $138,538 and $141,759, respectively. The 2% decrease in office lease and expenses during the 2019 period was primarily due to a decrease in utility expenditure incurred in the United States during the 2019 period.

Research and Development Costs – These costs consist of the salaries of personnel who are directly involved in the research and development of innovative products, as well as the direct costs associated with developing these products. Research and development costs for the six-month periods ended June 30, 2019 and 2018, increased to $706,315, from $702,192, during the same 2018 period. The 1% increase in research and development costs during the 2019 period is due to increased development costs as the Company continues to expand its product offering with exceptional protective gear and develop a pipeline of innovative products for wider consumer groups.

Bad Debt Expense – Bad Debt Expense for the six-month periods ended June 30, 2019 and 2018 were $9,499 and $20,472, respectively. This decrease in Bad Debt Expense during the 2019 period is primarily the result of a decrease in the Provision for doubtful accounts in line with a decrease in accounts receivable during the six-month period ended June 30, 2019 as compared to the six-month period ended June 30, 2018.

General and Administrative Expenses – General and administrative expenses consist of insurance, travel, merchant fees, telephone, office and computer supplies. General and administrative expenses for the six-month periods ended June 30, 2019 and 2018 were $988,654 and $889,716, respectively. The 11% increase in general and administrative expenses during the 2019 period is primarily as a result of an increase in product liability insurance premiums and increased expenditure on sales dealer visits in the United States.

Depreciation Expense – Depreciation Expense for the six-month periods ended June 30, 2019 and 2018 were $377,995 and $327,775, respectively. This 15% increase in depreciation during the 2019 period is primarily due to the addition of molds and tooling utilized in the production of the Company’s widening product range.

Total Operating Expenses – Total operating expenses increased by $394,407, to $5.39 million in the six-month periods ended June 30, 2019, or 8%, compared to $5 million in the 2018 period. This increase in total operating expenses during the 2019 period is primarily due to increased salaries, wages and general and administrative costs that were partially offset by decreased commission and consulting costs discussed above.

Net income – Net income after income taxes for the six-month period ended June 30, 2019 was $82,938 as opposed to a net income after income taxes of $91,364 for the six-month period ended June 30, 2018. This marginal decrease in net income during the 2019 period is primarily due to the increase in total operating expenses that were partially offset by the increase in revenue and gross profit discussed above.

Cash decreased by $217,553, or 13%, for the six months ended June 30, 2019 when compared to cash on hand at December 31, 2018. The primary uses of cash for the six months ended June 30, 2019 were increased inventory of $485,696, repayment of a short-term loan amounting to $291,296 and capital expenditures of $191,888. The primary sources of cash for the six months ended June 30, 2019 were decreased accounts receivable of $250,284 and net income of $82,938.

21

The Company is currently meeting its working capital needs through cash on hand as well as internally generated cash from operations. Management believes that its current cash and cash equivalent balances, along with the net cash generated by operations are sufficient to meet its anticipated operating cash requirements for at least the next twelve months. There are currently no plans for any major capital expenditures in the next twelve months. Our long-term financing requirements depend on our growth strategy, which relates primarily to our desire to increase revenue both in the U.S. and abroad.

Obligations under Material Contracts

Pursuant to our Licensing Agreement with Xceed Holdings, a company owned and controlled by Dr. Christopher Leatt, our founder, chairman and head of research and development, we pay Xceed Holdings 4% of all neck brace sales revenue billed and received by the Company on a quarterly basis based on sales of the previous quarter. In addition, pursuant to a separate license agreement between the Company and Mr. J. P. De Villiers, our former director, the Company is obligated to pay a royalty fee of 1% of all our billed and received neck brace sales revenue, in quarterly installments, based on sales of the previous quarter, to a trust that is beneficially owned and controlled by Mr. De Villiers. During the quarter ended June 30, 2019 and 2018, the Company paid an aggregate of $16,397 and $16,604 in licensing fees to Mr. De Villiers.

On July 8, 2015, the Company entered into a consulting agreement with Innovate Services Limited, or Innovate, a Seychelles limited company in which, Dr. Leatt is an indirect beneficiary. Pursuant to the terms of the Consulting Agreement, as amended, Innovate has agreed to serve as the Company’s exclusive research, development and marketing consultant, in exchange for a monthly fee of $38,062; provided that Dr. Leatt personally performs the services to be performed by Innovate under the Agreement, pursuant to a separate employment agreement between Innovate and Dr. Leatt. The parties further agreed that all intellectual property generated in connection with the services provided under the Consulting Agreement will be the sole property of the Company. The Consulting Agreement was effective as of May 15, 2015 and will continue unless terminated by either party in accordance with its terms. Either party has the right to terminate the Consulting Agreement upon 6 months' prior written notice, except that the Consulting Agreement may be terminated immediately without notice if the services to be performed under the Consulting Agreement cease to be performed by Dr. Leatt, or for any other material breach of the Agreement. The parties have agreed to settle any dispute under the Consulting Agreement through arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association (AAA), and that the resulting arbitration award will be final and binding on both parties and will not be subject to any appeal. Effective January 1, 2019, the Company and Innovate amended the Consulting Agreement to increase Innovate’s consulting duties and to increase the monthly fee payable under the agreement to $40,435. In addition, the parties agreed that Innovate may increase its monthly fees under the Consulting Agreement provided that the fee is no greater than the lesser of: (a) two and one-half percent (2.5%) of the prior year’s annualized fee; or (b) a percentage equal to then-applicable annual percentage increase in the Consumer Price Index published by the United States Department of Labor’s bureau of labor statistics, plus one-half percent (0.5%) . The foregoing description is qualified in its entirety by reference to the Consulting Agreement filed as Exhibit 10.14 to the Company’s report on Form 10-K for the year ended December 31, 2018. During the quarter ended June 30, 2019 and 2018, the Company paid an aggregate of $121,305 and $114,186 in consulting fees to Innovate.

The Company entered into a new Premium Finance Agreement with AFCO Acceptance Corporation “AFCO” dated October 10, 2018, to finance its U.S. short-term insurance over the period of coverage. The Company is obligated to pay AFCO an aggregate sum of $667,704 in eleven payments of $62,225, at an annual interest rate of 4.990% commencing on November 1, 2018 and ending on September 1, 2019. Any late payment during the term of the agreement will be assessed a late penalty of 5% of the payment amount due, and in the event of default AFCO has the right to accelerate the payment due under the agreement. As of June 30, 2019, the Company had not defaulted on its payment obligations under this agreement.

Pursuant to a Premium Finance Agreement, dated May 29, 2019, between the Company and AFCO, the Company is obligated to pay AFCO an aggregate sum of $112,538 in eleven payments of $10,540 at a 5.990% annual interest rate, commencing on June 1, 2019 and ending on April 1, 2020. Any late payment during the term of the agreement will be assessed a late penalty of 5% of the payment amount due, and in the event of default AFCO has the right to accelerate the payment due under the agreement. As of June 30, 2019, the Company had not defaulted on its payment obligations under this agreement.

On November 19, 2018, the Company entered into a $1,000,000 revolving line of credit agreement with a national bank. Payments for the advances under the line bear interest at the LIBOR Daily Floating Rate plus 2.5 percentage points, commencing January 1, 2019. The line of credit matures November 19, 2019, at which time the unpaid principal, interest, or other charges outstanding under the agreement are due and payable. Obligations under the line of credit are secured by the Company’s equipment and fixtures in the U.S., accounts receivable and inventory of the Company and its U.S. subsidiary, Two-Eleven. As of June 30, 2019, the line of credit was unused and the entire $1,000,000 was available.

22

Critical Accounting Policies

Our discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenues and expenses during the reporting period. We have identified the following as the items that require the most significant judgment and often involve complex estimation: revenue recognition, estimating allowances for doubtful accounts receivable, inventory valuation, impairment of long-lived assets and accounting for income taxes.

Revenue and Cost Recognition – The Company recognizes revenue in accordance with ASC 606. As such, the Company has and will continue to review its performance obligations in terms of material customer contractual arrangements in order to verify that revenue is recognized when performance obligations are satisfied on a periodic basis.

All manufacturing of Leatt-Brace products is performed by third party subcontractors in China. The Company's products are sold worldwide to a global network of distributors and dealers, and directly to consumers when there are no dealers or distributors in their geographic area or where consumers choose to purchase directly via the Company’s e-commerce website (collectively the "customers").

Revenues from product sales are recognized when earned, net of applicable provisions for discounts and returns and allowances in the event of product defect where no exchange of product is possible. Revenues are recognized when our performance obligations are satisfied as evidenced by transfer of control of promised goods to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Product royalty income, representing less than 1% of total revenues, is recorded as the underlying product sales occur, in accordance with the related licensing arrangements.

Our distributor payment terms range from pre-payment in full to 60 days after shipment and subsequent sales of our products by distributors have no effect on the amount and timing of payments due to us. Furthermore, products purchased by distributors may not be returned to us in the event that any such distributor relationship is terminated.

Since the Company (through its wholly-owned subsidiary) serves as the distributor of Leatt products in the United States, the Company records its revenue and related cost of revenue for its product sales in the United States upon shipment of the merchandise to the dealer or to the ultimate consumer when there is no dealer in the geographic area or the consumer chooses to purchase directly from the Company’s e-commerce website and the sales order was received directly from, and paid by, the ultimate consumer. Since the Company (through its South African branch) serves as the distributor of Leatt products in South Africa, the Company records its revenue and related cost of revenue for its product sales in South Africa upon shipment of the merchandise from the branch to the dealer.

The Company's standard terms and conditions of sale for non-consumer direct or web-based sales do not allow for product returns other than under warranty.

International sales (other than in the United States and South Africa) are generally drop-shipped directly from the third-party manufacturer to the international distributors. Revenue and related cost of revenue is recognized at the time of shipment from the manufacturer's port when the shipping terms are Free On Board ("FOB") shipping point, Cost and Freight ("CFR") or Cost and Insurance to named place ("CIP") as legal title and risk of loss to the product pass to the distributor. Sales to all customers (distributors, dealers and consumers) are generally final; however, in limited instances, product may be returned and exchanged due to product quality issues. Historically, returns due to product quality issues have not been material and there have been no distributor terminations that resulted in product returns. Cost of revenues also includes royalty fees associated with sales of Leatt-Brace products. Product royalty income is recorded as the underlying product sales occur, in accordance with the related licensing arrangements.

The Company reviews the reserves for customer returns at each reporting period and adjusts them to reflect data available at that time. To estimate reserves for returns, the Company estimates the expected returns and claims based on historical rates as well as events and circumstances that indicate changes to historical rates of product returns and claims. Historically, returns due to product quality issues have not been material and there have been no distributor terminations that resulted in product returns. No provision was made for estimated returns at June 30, 2019 and 2018, respectively.

Sales commissions are expensed when incurred, which is generally at the time of sale or cash received from customers, because the amortization period would have been one year or less. These costs are recorded in commissions and consulting expenses within operating expense in the accompanying consolidated statements of operations and comprehensive income (loss).

23

Shipping and handling activities associated with outbound freight, after control over a product has transferred to a customer, are accounted for as a fulfilment cost and are included in revenues and cost of revenues in the accompanying consolidated statements of operations and comprehensive income (loss).

Revenue recognized from contracts with customers is recorded net of sales taxes, value added taxes, or similar taxes that are collected on behalf of local taxing authorities.

For both the quarters ended June 30, 2019 and 2018, revenue recognized from performance obligations related to prior periods was not material. Revenue expected to be recognized in any future period related to remaining performance obligations is not material. As of June 30, 2019, contract liabilities, if any, were not material.

Allowance for Doubtful Accounts Receivable - Accounts receivable consist of amounts due to the Company from normal business activities. Credit is granted to substantially all distributors on an unsecured basis. We continuously monitor collections and payments from customers and maintain an allowance for doubtful accounts receivable based upon historical experience and any specific customer collection issues that have been identified. In determining the amount of the allowance, we are required to make certain estimates and assumptions. Accounts receivable balances that are still outstanding after we have used reasonable collection efforts are written off as uncollectible. While such credit losses have historically been minimal, within our expectations and the provisions established, we cannot guarantee that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of any of our significant customers could have a material adverse effect on the collectability of our accounts receivable and our future operating results. The allowance for doubtful accounts at June 30, 2019 was $85,493, and $83,399 at December 31, 2018.

Inventory Valuation – Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in first-out (FIFO) method. Inventory consists primarily of finished goods. Shipping and handling costs are included in the cost of inventory. In assessing the inventory value, we make estimates and judgments regarding reserves required for product obsolescence, aging of inventory and other issues potentially affecting the saleable condition of products. In performing such evaluations, we utilize historical experience as well as current market information. The reserve for obsolescence at June 30, 2019 was $75,906, and $83,004 at December 31, 2018.

Impairment of Long-Lived Assets – Our long-lived assets include property and equipment. We evaluate our long-lived assets for recoverability whenever events or changes in circumstances indicate that an asset may be impaired. In evaluating an asset for recoverability, we estimate the future cash flow expected to result from the use of the asset and eventual disposition. If the expected future undiscounted cash flow is less than the carrying amount of the asset, an impairment loss, equal to the excess of the carrying amount over the fair value of the asset, is recognized. We have determined there was no impairment charge during the six months ended June 30, 2019 and 2018, respectively.

Intangible Assets - The Company’s intangible assets consist of acquired patents with an indefinite useful life and are thus not amortized. Intangible assets are carried at cost less impairment. Amortization expense for both the six months ended June 30, 2019 and 2018 was zero. There was no impairment loss recognized for the six months ended June 30, 2019 and 2018, respectively.

Income Taxes - As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax provision (benefit) in each of the jurisdictions in which we operate. This process involves estimating our current income tax provision (benefit) together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheets. We regularly evaluate our ability to recover the reported amount of our deferred income taxes considering several factors, including our estimate of the likelihood of the Company generating sufficient taxable income in future years during the period over which the temporary differences reverse.

Recent Accounting Pronouncements

See Note 10, “Recent Accounting Pronouncements” in the Notes to Consolidated Financial Statements for a full description of recent accounting pronouncements, including the respective dates of adoption, or expected adoption and effects on our consolidated financial position, results of operations and cash flows.

24

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to its stockholders.